The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123932232 12393223 2 F 20140512 20160829 20160523 20160901 EXP US-PFIZER INC-2016267946 PFIZER 55.00 YR M Y 0.00000 20160901 LW US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123932232 12393223 1 PS DEPO-TESTOSTERONE TESTOSTERONE CYPIONATE 1 UNK, WEEKLY (ONCE A WEEK) U 85635 SOLUTION FOR INJECTION /wk
123932232 12393223 2 SS TESTOSTERONE CYPIONATE. TESTOSTERONE CYPIONATE 1 UNK, WEEKLY (ONCE A WEEK) U 0 /wk
123932232 12393223 3 C NISOLDIPINE. NISOLDIPINE 1 UNK 0
123932232 12393223 4 C ASPIRIN. ASPIRIN 1 UNK 0
123932232 12393223 5 C LISINOPRIL. LISINOPRIL 1 UNK 0
123932232 12393223 6 C ATENOLOL-CHLORTHALIDONE 2 UNK 0
123932232 12393223 7 C ALBUTEROL. ALBUTEROL 1 UNK 0
123932232 12393223 8 C ALBUTEROL. ALBUTEROL 1 0
123932232 12393223 9 C MOMETASONE MOMETASONE 1 UNK 0
123932232 12393223 10 C PROTONIX PANTOPRAZOLE SODIUM 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123932232 12393223 1 Hormone replacement therapy
123932232 12393223 2 Hormone replacement therapy
123932232 12393223 3 Hypertension
123932232 12393223 4 Ischaemic heart disease prophylaxis
123932232 12393223 5 Blood pressure abnormal
123932232 12393223 6 Blood pressure abnormal
123932232 12393223 7 Respiratory tract congestion
123932232 12393223 8 Hypersensitivity
123932232 12393223 9 Respiratory tract congestion
123932232 12393223 10 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
123932232 12393223 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123932232 12393223 Anxiety
123932232 12393223 Blindness
123932232 12393223 Cerebrovascular accident
123932232 12393223 Emotional distress
123932232 12393223 Retinal vein occlusion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123932232 12393223 1 201401 20140512 0
123932232 12393223 2 201207 201401 0
123932232 12393223 3 2006 0
123932232 12393223 4 2006 0
123932232 12393223 5 2006 0
123932232 12393223 6 2006 0
123932232 12393223 7 2006 0
123932232 12393223 9 2006 0
123932232 12393223 10 2006 0